All terms in HP

Label Id Description
Microform unilateral cleft lip HP_5201002 [Notch, groove, or scar of the upper lip without noticeable rupture of the lip. Microforms are sometimes associated with disruption of the continuity of the orbicularis oris muscle.]
Unilateral cleft lip HP_0100333 [A non-midline cleft of the upper lip on one side only.]
Complete unilateral cleft lip HP_5201001 [Unilateral cleft lip cleft that starts from the bottom of the upper lip and reaches the nasal cavity.]
Incomplete cleft hard palate HP_5201004 [Cleft hard palate in which the cleft does not go through the entire length of the hard palate, ie. the cleft does not go from the incisor foramen to the anterior border of the soft palate.]
Complete cleft hard palate HP_5201003 [Cleft hard palate in which the cleft goes through the entire length of the hard palate, ie. from the incisor foramen to the anterior border of the soft palate.]
Incomplete unilateral cleft lip HP_5201000 [Unilateral cleft lip cleft that starts from the bottom of the upper lip but does not reach the nasal cavity.]
Incomplete cleft of the upper lip HP_0011340 [Cleft of the upper lip that does not go all the way from the bottom of the upper lip until the nasal cavity.]
negative regulation of cartilage development GO_0061037 [Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.]
regulation of cartilage development GO_0061035 [Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.]
Abnormal granulocyte morphology HP_0001911 [Any structural abnormality or abnormal count of granulocytes.]
positive regulation of cartilage development GO_0061036 [Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.]
Increased circulating procalcitonin concentration HP_0032308 [An elevated concentration of procalcitonin in the blood circulation.]
Abnormal circulating calcium-phosphate regulating hormone concentration HP_0100530 [Any deviation from the normal concentration in the blood circulation of a hormone that is involved in the regulation of phosphate and calcium.]
Elevated circulating mannose-binding protein concentration HP_0032306 [The concentration of mannose-binding protein in the blood circulation is above the upper limit of normal.]
Abnormal circulating mannose-binding protein concentration HP_0032304 [Any deviation from the normal concentration of mannose-binding protein in the blood circulation.]
Decreased circulating mannose-binding protein concentration HP_0032305 [The concentration of mannose-binding protein in the blood circulation is below the lower limit of normal.]
Hypoplasia of the pyramidal tract HP_0007348
Aplasia/Hypoplasia of the pyramidal tract HP_0007363
Lambda Bence Jones proteinuria HP_0032303 [The presence of free monoclonal lambda immunoglobulin light chains in the urine.]
Bence Jones Proteinuria HP_0030156 [The presence of free monoclonal immunoglobulin light chains in the urine.]